JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for PHATHOM PHARMACEUTICALS · biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $15,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Issues related to drug approval

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem